The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
GeneHarbor (Hong Kong) Biotechnologies Limited works on active pharmaceutical ingredients [API] and/or intermediates via enzymatic approach, servicing pharma manufacturing. The company has developed a proprietary platform technology for production of various enzymes. The technology aims to reduce the cost & increase the life span of the enzymes. The company is developing a novel technology for purification of monoclonal antibodies. This will facilitate the development of monoclonal antibody drugs in the future.